Brexpiprazole combined analysis shows schizophrenia safety, efficacy

MADRID – Brexpiprazole, a new drug for treatment of schizophrenia that received Food and Drug Administration marketing approval in July 2015, showed good efficacy for patients with acute...
Source: Clinical Psychiatry News - Category: Psychiatry Source Type: research